RNS Number : 7366X Renalytix AI PLC 02 September 2020     Renalytix AI plc ("RenalytixAI", the "Company")   Grant of Purchase Rights under the 2020 Employee Share Purchase Plan and Verici update   NEW YORK , September 2, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX) announces that on 28

RNS Number : 1457X Renalytix AI PLC 26 August 2020   Renalytix AI plc ("RenalytixAI", the "Company")   RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX     NEW YORK , August 26, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX), an artificial intelligence -enabled in vitro

RNS Number : 7551W Renalytix AI PLC 21 August 2020     Renalytix AI plc ("RenalytixAI", the "Company")   RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease   Parties to adopt multi-phase approach to develop precision medicine strategies to optimize

RNS Number : 8477U Renalytix AI PLC 03 August 2020     Renalytix AI plc ("RenalytixAI", the "Company")   KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients     Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19   Mount Sinai-Led Study

RNS Number : 8003U Renalytix AI PLC 31 July 2020       Renalytix AI plc   (the "Company")    Total Voting Rights   For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following:   As of 31 July 2020 , the Company's issued and fully paid share capital

RNS Number : 0885U Renalytix AI PLC 27 July 2020       Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction   Renalytix AI plc   Over allotment option exercise

RNS Number : 6782T Renalytix AI PLC 21 July 2020         Renalytix AI plc   Closing of Global Offering and resulting total voting rights   Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX) (" RenalytixAI " or the " Company "), an artificial intelligence -enabled   in vitro   diagnostics company,

RNS Number : 3256T Renalytix AI PLC 17 July 2020         This announcement contains inside information   Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction  

Download  full announcement Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled  in vitro  diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that all resolutions proposed at the

Download  full announcement Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled  in vitro  diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, today announces the commencement of an underwritten